Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M800450-JLR200 on December 3, 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M800450-JLR200v1
50/4/641    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyanovsky, B. B.
Right arrow Articles by Webb, N. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyanovsky, B. B.
Right arrow Articles by Webb, N. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 50, 641-650, April 2009
Copyright © 2009 by American Society for Biochemistry and Molecular Biology

Syndecan-4 mediates macrophage uptake of group V secretory phospholipase A2-modified LDL*

Boris B. Boyanovsky*, Preetha Shridas{dagger}, Michael Simons**, Deneys R. van der Westhuyzen*,{dagger},§ and Nancy R. Webb1,*,{dagger},§

* Department of Internal Medicine, Endocrinology Division, University of Kentucky Medical Center, Lexington, KY 40536
{dagger} Cardiovascular Research Center, University of Kentucky Medical Center, Lexington, KY 40536
§ Graduate Center for Nutritional Sciences, University of Kentucky Medical Center, Lexington, KY 40536
** Yale University School of Medicine, New Haven, CT 06520

* This work was funded by National Institutes of Health Grant RO1HL-071098 to N.R.W. The authors thank Kathy Forrest and William Bailey for excellent technical assistance.

Published, JLR Papers in Press, December 3, 2008.

1 To whom correspondence should be addressed. e-mail: nrwebb1{at}uky.edu

We previously reported that LDL modified by group V secretory phospholipase A2 (GV-LDL) promotes macrophage foam cell formation through a mechanism independent of scavenger receptors SR-A and CD36, and dependent on cellular proteoglycans. This study investigates the role of syndecans, a family of cell surface proteoglycans known to mediate endocytosis through macropinocytosis, in macrophage uptake of GV-LDL. LY 294002, a phosphatidylinositol 3-kinase inhibitor, significantly reduced internalization of 125I-labeled GV-LDL in J-774 macrophages, consistent with a macropinocytic uptake pathway. Using small, interfering RNA-directed gene silencing, we demonstrated a direct relationship between 125I-labeled GV-LDL binding and the level of syndecan-3 and syndecan-4 expression in J-774 cells. However, 125I-labeled GV-LDL uptake was significantly reduced only when syndecan-4 expression was suppressed. Peritoneal macrophages from syndecan-4-deficient mice exhibited markedly reduced uptake of fluorescently labeled GV-LDL compared with wild-type cells. Furthermore, cholesteryl ester accumulation induced by GV-LDL was dependent on syndecan-4 expression. Syndecan-4 expression and GV-LDL binding were significantly increased in J-774 cells treated with lipopolysaccharide, suggesting that GV-LDL uptake via this pathway may be enhanced during inflammation. Taken together, our data point to a novel role for syndecan-4 in mediating the uptake of GV-LDL, a process implicated in atherosclerotic lesion progression.

Supplementary key words atherosclerosis • foam cells • macropinocytosis • proteoglycan • lipoprotein modification

Abbreviations: apoB-100, apolipoprotein B-100; CE, cholesteryl ester; ECM, extracellular matrix; GAG, glucosaminoglycan; GV, group V; HSPG, heparan sulfate proteoglycan; LPS, lipopolysaccharide; MPM, mouse peritoneal macrophage; ox-LDL, oxidized LDL; PI, phosphatidylinositol; sPLA2, secretory phospholipase A2


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
A. S. Haka, I. Grosheva, E. Chiang, A. R. Buxbaum, B. A. Baird, L. M. Pierini, and F. R. Maxfield
Macrophages Create an Acidic Extracellular Hydrolytic Compartment to Digest Aggregated Lipoproteins
Mol. Biol. Cell, December 1, 2009; 20(23): 4932 - 4940.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Grosheva, A. S. Haka, C. Qin, L. M. Pierini, and F. R. Maxfield
Aggregated LDL in Contact With Macrophages Induces Local Increases in Free Cholesterol Levels That Regulate Local Actin Polymerization
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1615 - 1621.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. J. Williams
Some Things Just Have to Be Done In Vivo: GPIHBP1, Caloric Delivery, and the Generation of Remnant Lipoproteins
Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 792 - 795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement